| Literature DB >> 8825117 |
I Pastan1, L H Pai, U Brinkmann, D FitzGerald.
Abstract
Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8825117 DOI: 10.1007/BF01803778
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN: 0167-6806 Impact factor: 4.624